Echo

Experts in communication,
brand and reputation research

  • Home
  • About
    • Overview
    • Echo Team
    • Advisory Board
    • Careers
  • Services
    • Reputation Audit
    • Market & Stakeholder Research
    • Publicity & Thought Leadership Research
    • Media Monitoring & Analysis
    • Risk & Issues Monitoring
    • Influencer Mapping
    • Reputation Valuation
    • Communications Leadership Forum & The Academy for Communication Excellence
    • Britain’s Most Admired Companies
    • ESG BALANCED SCORECARD
  • Sectors
    • Consumer
    • Healthcare & Pharmaceuticals
    • Professional & Financial
    • Public, Government & Not-For-Profit
    • Technology, Media & Telecoms
    • Industry & Utilities
  • Case Studies
    • American Express
    • BitMEX
    • BT
    • Global Self-Care Federation
    • GSK
    • Innovate UK
    • Johnson & Johnson
    • Major FMCG Food Company
    • Moderna
    • Shire
    • UK Power Networks
    • World Wildlife Fund
    • Zurich
  • News & Events
  • Contact
    • Make an enquiry
    • Our Offices

SPEAKER

Mobilizing Reputation in the Recovery, 28th July 2021

Lez Cunningham
Former VP, Global Communications & Public Affairs, Agilent Technologies

Lez Cunningham is a corporate communications executive with more than 20 years of experience with multinational corporations. She has been recognized as a subject matter expert on corporate reputation, issues management and public policy. Lez has lived and worked in North America and Asia, led global teams and has built and scaled Communications and Corporate Affairs functions for multi-national organizations.

Most recently, Lez was the Chief Communications Officer and Vice President of Public Affairs for Agilent Technologies, a global                                                                          leader in life sciences, diagnostics and applied chemicals. She                                                                              also served in leading communication roles for IQVIA, Avanir                                                                               Pharmaceuticals and Johnson & Johnson.

© 2022 Echo Group Limited

  • Terms of use
  • Policies
  • Modern Slavery Act
Sign up for echo news Contact us